Aarti Pharmalabs Ltd Share Price
(AARTIPHARM)
₹722.55▲6.27%
as on 11:43AM, 07 Feb 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 1.8 % |
3 Month Return | -1.18 % |
1 Year Return | + 21.89 % |
Market Stats | |
Previous Close | ₹679.95 |
Open | ₹722.15 |
Volume | 92.49L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹6,162.12Cr |
P/E Ratio
24.72
PEG Ratio
4.09
Market Cap
₹6,162.12 Cr
P/B Ratio
2.43
EPS
23.93
Dividend Yield
0.69
Sector
Pharmaceuticals
ROE
13.11
Key events for Aarti Pharmalabs Ltd
Aarti Pharmalabs Resumes Manufacturing at Vapi Plant - 18 Jan, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, AARTIPHARM stock has moved up by 16.3%
Revenue Rich
Revenue is up for the last 2 quarters, 462.51 Cr → 542.81 Cr (in ₹), with an average increase of 14.8% per quarter
Profit Spike
Netprofit is up for the last 2 quarters, 54.62 Cr → 73.99 Cr (in ₹), with an average increase of 26.2% per quarter
FII Holding Up
Foreign Institutions have increased holdings from 7.38% to 8.64% in Dec 2024 quarter
Retail Holding Up
Retail Investor have increased holdings from 35.16% to 36.33% in Dec 2024 quarter
MF Holding Down
Mutual Funds have decreased holdings from 4.93% to 3.93% in Dec 2024 quarter
Promoter Holding Down
Promoters have decreased holdings from 46.10% to 44.66% in Dec 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 44.66% | ||
Foreign Institutions | 8.64% | 17.15 | |
Mutual Funds | 3.93% | ||
Retail Investors | 36.33% | 3.33 | |
Others | 6.44% | 0.07 |
Aarti Pharmalabs Ltd in the last 5 years
Lowest (11.23x)
February 2, 2023
Today (24.72x)
February 6, 2025
Industry (54.99x)
February 6, 2025
Highest (28.14x)
August 29, 2024
Aarti Pharmalabs Ltd’s net profit jumped 40.24% since last year same period to ₹73.99Cr in the Q3 2024-2025. On a quarterly growth basis, Aarti Pharmalabs Ltd has generated 35.46% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Aarti Pharmalabs Ltd has declared dividend of ₹1 - translating a dividend yield of 0.44%.
Read More about DividendsBearish
Neutral
Bullish
Aarti Pharmalabs Ltd is currently in a Bullish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹6,162.12 Cr | 27.18% | 0.57 | ₹216 Cr | ₹1,852 Cr | |
NA | ₹4,080.42 Cr | 15.99% | 0.52 | -₹30 Cr | ₹1,369 Cr | |
NA | ₹166.37 Cr | 173% | 0.50 | ₹9 Cr | ₹188 Cr | |
BUY | ₹5,439.52 Cr | 15.11% | 0.63 | ₹94 Cr | ₹1,081 Cr | |
NA | ₹2,627.96 Cr | 52.56% | 0.65 | -₹2 Cr | ₹559 Cr |
Organisation | Aarti Pharmalabs Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Aarti Pharmalabs Ltd share price today stands at ₹722.55, Open: ₹722.15, Previous Close: ₹679.95, High: ₹723.8, Low: ₹669.75, 52 Week High: ₹723.8, 52 Week Low: ₹399.55.
Aarti Pharmalabs Ltd is listed on NSE
Aarti Pharmalabs Ltd is listed on BSE
Today's traded volume of Aarti Pharmalabs Ltd(AARTIPHARM) is 92.49L.
Today's market capitalisation of Aarti Pharmalabs Ltd(AARTIPHARM) is ₹6162.12Cr.
Aarti Pharmalabs Ltd (AARTIPHARM) share price is ₹722.55. It is down -0.17% from its 52 Week High price of ₹723.8
Aarti Pharmalabs Ltd (AARTIPHARM) share price is ₹722.55. It is up 80.84% from its 52 Week Low price of ₹399.55
PE Ratio of Aarti Pharmalabs Ltd is 24.72
PE ratio = Aarti Pharmalabs Ltd Market price per share / Aarti Pharmalabs Ltd Earnings per share